By IPOdesktop:
Based in Rehovot, Israel, Foamix Pharmaceuticals, Ltd. (Pending:FOMX) scheduled a $65 million IPO on the Nasdaq with a market capitalization of $234 million at a price range midpoint of $11 for Thursday, Sept. 18, 2014.
The full IPO calendar is available at IPOpremium